Customer Testimonials at Quotient Sciences

Cambridge Drug Development Workshop

Cambridge, UK | 30 April 2024

Join us for an insightful seminar taking place at Babraham Research Centre, Cambridge.

At Quotient Sciences, we strive to deliver a full-service drug development offering that meets the needs of the industry and our customers. The purpose of this event is to connect with you to ensure that we are aligned and aware of the challenges that you are facing and to get your input on the needs, drivers and service gaps that exist in the CDMO/CRO sector to better support you.

In this presentation, Dr. Valeria Ciarnelli, Senior Director of Product Development, and Dr. Andrew Parker, Senior Drug Development Consultant, will discuss considerations when navigating the pre-clinical to clinical transition, delving into the regulatory expectations and the needs of enabling technologies for poorly soluble molecules, among other topics.

Our speakers will review the solutions that our team have developed to help customers successfully navigate through development milestones, leveraging the Quotient Sciences Translational Pharmaceutics® platform. They will share rationale for assessing amorphous solid dispersions when compared with lipidics and size reduction, and show how these can be easily translated into fit-for-purpose, first-in-human (FIH) presentations suitable for oral administration and enabling dose escalation.

Key learning objectives:

  • How to identify the best development strategy, technology(s) and candidate(s), demonstrate solubility improvement and stability.
  • Justify selection of prototypes as being suitable for testing in animals and potentially improving exposure to meet toxicology multiples required to justify entering a FIH study.
  • Where to invest from early stage, modularity of the preclinical screen and how it can be refined based on your needs.

Please drop in for lunch and a catch up with our experts, register using the link below as soon as possible so we can reserve your seat. 


Tuesday, April 30, 2024

Registration 10-10:30 AM
Presentation 10:30-11:30 AM
Networking & Lunch 11:30-1 PM

Queen Edith's Room
The Cambridge Building
Babraham Research Campus
Cambridge CB22 3AT


 *We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.


Registration 10-10:30 AM
Presentation 10:30-11:30 AM
Networking & Lunch 11:30-1 PM

Queen Edith's Room, The Cambridge Building
Babraham Research Campus, Cambridge CB22 3AT
Cambridge, UK

Meet our experts:

We look forward to meeting you at our Drug Development Workshop in Cambridge.

Dr. Andrew Parker

Senior Drug Development Consultant

Dr. Andrew Parker has two decades of experience in the pharmaceutical industry, spanning from preclinical development, through ear...

Contact Us
Dr. Valeria Ciarnelli

Senior Director of Product Development

Dr. Valeria Ciarnelli is a Senior Director of Product Development at Quotient Sciences, with responsibility for scientific program...

Contact Us
Charlotte Hannigan

Associate Director, Business Development

With a chemistry background, I have technical and commercial experience in the pharmaceutical industry, spanning a range of discip...

About Charlotte

More insight from our experts:

Read More
Oncology, Translational Pharmaceutics, Dr. Paul Quigley Insight from our experts: How Translational Pharmaceutics accelerates oncology clinical trials By: Dr. Paul Quigley
Read More
Oncology, Translational Pharmaceutics, John McDermott A Smarter Strategy for Optimizing Oncology Drug Products By: John McDermott
Read More